lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - Žiarenie zranenia - detoxifying agents for antineoplastic treatment - lysakare je indikovaný na zníženie renálnej žiarenie počas peptid-receptor rádionuklidov terapia (prrt) s lutetium (177lu) oxodotreotide v dospelí.
lenzetto 1,53 mg/dávka
gedeon richter plc., maďarsko - estradiol - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
estradiol besins 0,75 mg/dávka transdermálny gél
laboratories besins international, francúzsko - estradiol - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
vagirux 10 mikrogramov vaginálne tablety
gedeon richter plc., maďarsko - estradiol - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
gonasi kit
ibsa slovakia s.r.o., slovensko - choriový gonadotropín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiká - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiká - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiká - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
raptiva
serono europe limited - efalizumab - svrab - imunosupresíva - liečba dospelých pacientov so stredne závažnou až závažnou chronickou plakovou psoriázou, ktorí nedokázali odpovedať, alebo ktorí majú kontraindikácie alebo intoleranciu na iné systémové terapie, vrátane cyklosporínu, metotrexátu a puva (pozri časť 5. 1 - klinická účinnosť).
fortacin
recordati ireland ltd. - lidokaín, prilocaine - sexuálna dysfunkcia, fyziologické - anestetiká - liečba primárnej predčasnej ejakulácie u dospelých mužov.